Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCZD1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,213
Award facts
- Contract value 100% obligated
- $14,212.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,212.98 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The contract, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide DLA with firm fixed-price delivery orders for comprehensive pharmaceutical products, including biologics and medical consumables, to support the Department of Defense's global military healthcare operations. As a critical pharmaceutical supplier within this framework, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity with numerous delivery orders reflecting its capability to fulfill diverse specialized pharmaceutical requirements for the military medical system.
Quick answers
Who was awarded contract SPE2DR26FCZD1?
SPE2DR26FCZD1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FCZD1 worth?
The government has obligated $14,213 on SPE2DR26FCZD1.
Is contract SPE2DR26FCZD1 an order under another contract?
Yes. SPE2DR26FCZD1 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZD1 competed?
The extent of competition for SPE2DR26FCZD1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award